Amplify Surgical

Amplify Surgical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $15M

Overview

Founded in 2014, Amplify Surgical is a medical technology company dedicated to transforming spine surgery through minimally invasive and endoscopic solutions. Its mission is to improve patient safety and outcomes by providing surgeons with groundbreaking tools like the dualPortal® endoscopic system and dualX® expandable interbody implants. The company leverages a seasoned leadership team with deep experience in spinal device development and commercialization, having previously contributed to major platforms at companies like Stryker and Alphatec Spine. Amplify Surgical operates as a private, commercial-stage company, focusing on surgeon education and adoption of its novel techniques.

OrthopedicsSpine Surgery

Technology Platform

An integrated platform featuring the dualPortal® two-portal endoscopic surgical approach for spine access and the dualX® family of expandable interbody implants designed for minimally invasive and endoscopic lumbar fusion procedures.

Funding History

1
Total raised:$15M
Series A$15M

Opportunities

The company is positioned to capitalize on the fast-growing segment of minimally invasive and endoscopic spine surgery.
Key opportunities include displacing traditional open surgeries, expanding its surgeon training programs globally, and potentially leveraging its integrated platform to enter adjacent spinal procedure markets.
Its technology also makes it an attractive future acquisition target for larger medical device companies.

Risk Factors

Primary risks include intense competition from large, well-capitalized medical device conglomerates, the challenge and cost of driving surgeon adoption of a new technique, dependence on continued investment or revenue growth as a private company, and the potential for technological obsolescence or competitive imitation.

Competitive Landscape

Amplify Surgical competes against major spinal device companies like Medtronic, Stryker, and Johnson & Johnson, as well as pure-play spine firms like Globus Medical and Alphatec Spine. Its key differentiation is the synergistic dualPortal® two-portal endoscopic technique and the dualX® Slim expandable cage designed specifically for it, offering a potentially superior solution for endoscopic lumbar fusion compared to single-portal systems.